198 related articles for article (PubMed ID: 37965466)
1. Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients-results of KRANIOPHARYNGEOM 2007.
Friedrich C; Boekhoff S; Bischoff M; Beckhaus J; Sowithayasakul P; Calaminus G; Eveslage M; Valentini C; Bison B; Harrabi SB; Krause M; Timmermann B; Müller HL
Front Oncol; 2023; 13():1180993. PubMed ID: 37965466
[TBL] [Abstract][Full Text] [Related]
2. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.
Müller HL; Gebhardt U; Pohl F; Flentje M; Emser A; Warmuth-Metz M; Kolb R; Calaminus G; Sörensen N
Klin Padiatr; 2006; 218(6):315-20. PubMed ID: 17080333
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and Toxicities of Proton and Photon Radiation Therapy for Testicular Seminoma.
Pasalic D; Prajapati S; Ludmir EB; Tang C; Choi S; Kudchadker R; Frank SJ
Int J Part Ther; 2020; 7(2):11-20. PubMed ID: 33274253
[TBL] [Abstract][Full Text] [Related]
4. Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage.
Beckhaus J; Friedrich C; Boekhoff S; Calaminus G; Bison B; Eveslage M; Timmermann B; Flitsch J; Müller HL
Eur J Endocrinol; 2023 Mar; 188(3):. PubMed ID: 36857103
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.
Heinks K; Boekhoff S; Hoffmann A; Warmuth-Metz M; Eveslage M; Peng J; Calaminus G; Müller HL
Endocrine; 2018 Feb; 59(2):364-372. PubMed ID: 29230635
[TBL] [Abstract][Full Text] [Related]
6. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
[TBL] [Abstract][Full Text] [Related]
7. Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.
Müller HL; Bueb K; Bartels U; Roth C; Harz K; Graf N; Korinthenberg R; Bettendorf M; Kühl J; Gutjahr P; Sörensen N; Calaminus G
Klin Padiatr; 2001; 213(4):244-9. PubMed ID: 11528558
[TBL] [Abstract][Full Text] [Related]
8. Brainstem toxicity after proton or photon therapy in children and young adults with localized intracranial ependymoma: A French retrospective study.
Dalmasso C; Alapetite C; Bolle S; Goudjil F; Lusque A; Desrousseaux J; Claude L; Doyen J; Bernier-Chastagner V; Ducassou A; Sevely A; Roques M; Tensaouti F; Laprie A
Radiother Oncol; 2024 May; 194():110157. PubMed ID: 38367939
[TBL] [Abstract][Full Text] [Related]
9. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
Bishop AJ; Greenfield B; Mahajan A; Paulino AC; Okcu MF; Allen PK; Chintagumpala M; Kahalley LS; McAleer MF; McGovern SL; Whitehead WE; Grosshans DR
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):354-61. PubMed ID: 25052561
[TBL] [Abstract][Full Text] [Related]
10. Pseudoprogression Is Frequent After Front-Line Radiation Therapy in Pediatric Low-Grade Glioma: Results From the German Low-Grade Glioma Cohort.
Stock A; Hancken CV; Kandels D; Kortmann RD; Dietzsch S; Timmermann B; Pietsch T; Bison B; Schmidt R; Pham M; Gnekow AK; Warmuth-Metz M
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1190-1202. PubMed ID: 34933039
[TBL] [Abstract][Full Text] [Related]
11. Vision-related quality of life in patients with childhood-onset craniopharyngioma.
Sowithayasakul P; Beckhaus J; Boekhoff S; Friedrich C; Calaminus G; Müller HL
Sci Rep; 2023 Nov; 13(1):19599. PubMed ID: 37949931
[TBL] [Abstract][Full Text] [Related]
12. A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity.
Uchinami Y; Katoh N; Suzuki R; Kanehira T; Tamura M; Takao S; Matsuura T; Miyamoto N; Fujita Y; Koizumi F; Taguchi H; Yasuda K; Nishioka K; Yokota I; Kobashi K; Aoyama H
Clin Transl Radiat Oncol; 2022 Jul; 35():70-75. PubMed ID: 35633653
[TBL] [Abstract][Full Text] [Related]
13. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
[TBL] [Abstract][Full Text] [Related]
14. Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma.
Bogusz A; Boekhoff S; Warmuth-Metz M; Calaminus G; Eveslage M; Müller HL
Endocr Connect; 2019 May; 8(5):481-492. PubMed ID: 30925462
[TBL] [Abstract][Full Text] [Related]
15. Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity.
Ravindra VM; Okcu MF; Ruggieri L; Frank TS; Paulino AC; McGovern SL; Horne VE; Dauser RC; Whitehead WE; Aldave G
J Neurosurg Pediatr; 2021 May; 28(2):152-159. PubMed ID: 34049281
[TBL] [Abstract][Full Text] [Related]
16. Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg.
Bischoff M; Khalil DA; Frisch S; Bäcker CM; Peters S; Friedrich C; Tippelt S; Kortmann RD; Bison B; Müller HL; Timmermann B
Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38492813
[TBL] [Abstract][Full Text] [Related]
17. Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
Jazmati D; Butzer S; Hero B; Ahmad Khalil D; Merta J; Bäumer C; Plum G; Fuchs J; Koerber F; Steinmeier T; Peters S; Doyen J; Thole T; Schmidt M; Blase C; Tippelt S; Eggert A; Schwarz R; Simon T; Timmermann B
Front Oncol; 2020; 10():617506. PubMed ID: 33552991
[TBL] [Abstract][Full Text] [Related]
18. Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
Jhaveri J; Cheng E; Tian S; Buchwald Z; Chowdhary M; Liu Y; Gillespie TW; Olson JJ; Diaz AZ; Voloschin A; Eaton BR; Crocker IR; McDonald MW; Curran WJ; Patel KR
Front Oncol; 2018; 8():440. PubMed ID: 30547008
[No Abstract] [Full Text] [Related]
19. Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses.
Dutz A; Lühr A; Troost EGC; Agolli L; Bütof R; Valentini C; Baumann M; Vermeren X; Geismar D; Timmermann B; Krause M; Löck S
Radiother Oncol; 2021 Jul; 160():69-77. PubMed ID: 33872640
[TBL] [Abstract][Full Text] [Related]
20. Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton.
Uchinami Y; Katoh N; Abo D; Morita R; Taguchi H; Fujita Y; Kanehira T; Suzuki R; Miyamoto N; Takao S; Matsuura T; Sho T; Ogawa K; Orimo T; Kakisaka T; Kobashi K; Aoyama H
Br J Radiol; 2023 Mar; 96(1144):20220720. PubMed ID: 36633335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
